Education: Doctor of Pharmacy, Northeastern University (2016)

Residency: PGY1, NewYork-Presbyterian Hospital  (2017), PGY2 Solid Organ Transplant, NewYork-Presbyterian Hospital (2018)

Practice/Research Interests: Immunology/ immunosuppression, transplant infectious disease, medication adherence

Select Publications: 

Mecadon K, Hardesty A, Vieira K, Rogers R, Merhi B, Osband A, Bayliss G, Gohh R,  Morrissey P, Farmakiotis D. Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients. Ann Pharmacother. 2022. [In press]

Mecadon K. Managing Side Effects of Immunosuppressants. R I Med J. 2021;104(1):31-33. 

Shi Y, Lerner A, Rogers R, Vieira K, Merhi B, Mecadon K, Osband AJ, Bayliss G, Gohh R,  Morrissey P, Farmakiotis D. Half-dose valganciclovir prophylaxis is safe and cost-saving in CMV seropositive kidney transplant recipients. Prog Transplant. 2021;31(4):368-376.

Krista Mecadon, PharmD is a clinical pharmacy specialist in solid organ transplant at Rhode Island Hospital, participating in multidisciplinary rounds with the kidney transplant team and in the outpatient transplant clinic. Dr. Mecadon serves as a guest lecturer for Johnson & Wales University and Bryant University, in addition to precepting students from local colleges of pharmacy.